Overall Status

Completed (374)

Terminated (72)

Unknown status (36)

Active, not recruiting (13)

Recruiting (13)

Withdrawn (12)

Not yet recruiting (6)

No longer available (2)

Suspended (1)

Phase

phase 2 (178)

phase 3 (123)

phase 1 (91)

phase 1/phase 2 (45)

n/a (35)

phase 4 (11)

early phase 1 (4)

phase 2/phase 3 (2)

Study Documents

Clinical Study Report (1)

Dataset Specification (1)

Individual Participant Data Set (1)

Informed Consent Form (1)

Statistical Analysis Plan (1)

Study Protocol (1)

Funder Type

Other (358)

Industry (152)

NIH (19)

Study Type

Interventional (489)

Observational (37)

Expanded Access (2)

Observational [Patient Registry] (1)

Plasmacytoma

Showing 526 - 529 of 529

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Worldwide (busulfan, cyclophosphamide, idarubicin)

Unknown status

Leukemia
+3 more

busulfan
+4 more

Brussels (Bruxelles), Belgium
+8 more

Feb 6, 2009

Obesity Trial in North Chicago (Sibutramine HCl, Placebo)

Completed

Has Results

Obesity

Sibutramine hydrochloride
Placebo

North Chicago, Illinois

Global Medical Services

May 6, 2010

Atrial Fibrillation, Atrial Flutter Trial in Worldwide (dronedarone (SR33589), )

Completed

Has Results

Atrial Fibrillation
Atrial Flutter

dronedarone (SR33589)
placebo

Bridgewater, New Jersey
+36 more

Jan 5, 2010

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Seoul (L-Ascorbic Acid)

Suspended

Acute Myeloid Leukemia
Myelodysplastic Syndrome

L-Ascorbic Acid

Seoul, Korea, Republic of

Samsung Medical Center

Oct 25, 2006